Live Breaking News & Updates on அலை போது

Stay updated with breaking news from அலை போது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neurocrine Biosciences Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones


Share this article
Share this article
SAN DIEGO, Jan. 8, 2021 /PRNewswire/  Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today provided an update on its business performance, including preliminary net product and inventory adjusted sales results of INGREZZA
® (valbenazine) for 2020, and key commercial and clinical development milestones for 2021. Kevin Gorman, Chief Executive Officer of Neurocrine Biosciences, will discuss these updates as part of a webcast presentation at the 39
th Annual J.P. Morgan Healthcare Conference to be held virtually on Monday, January 11 at 2:00 p.m. Eastern Time, followed by a Question and Answer session at approximately 2:20 p.m. Eastern Time.
Preliminary Fourth Quarter and Full-Year 2020 ....

Neurocrine Biosciences , Kevin Gorman , Neurocrine Biosciences Inc , Chief Executive Officer , Healthcare Conference , Fourth Quarter , Net Product Sales , Inventory Adjusted Net Product Sales , Line Data Expected , Adrenal Hyperplasia , Pediatric Epilepsy , Continuous Spike , Wave During , Onset Seizure , Regulatory Path , Tardive Dyskinesia , கெவின் கோர்மந் , தலைமை நிர்வாகி அதிகாரி , சுகாதாரம் மாநாடு , நான்காவது காலாண்டு , நிகர ப்ராடக்ட் விற்பனை , வரி தகவல்கள் எதிர்பார்க்கப்படுகிறது , குழந்தை கால் கை வலிப்பு , தொடர்ச்சியான ஸ்பைக் , அலை போது , தொடக்கம் வலிப்பு ,